Evidence map›Paper›PMID 26209570›Full record

ArticleSurgery2015

Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.

Letitia E Bible, Latha V Pasupuleti, Amy V Gore, Ziad C Sifri, Kolenkode B Kannan, Alicia M Mohr

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Persistent injury-associated anemia and aging: Novel insights.The journal of trauma and acute care surgery · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Severe trauma and chronic stress activates extramedullary erythropoiesis.The journal of trauma and acute care surgery · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Letitia E BibleDepartment of Surgery, Division of Trauma, Rutgers-New Jersey Medical School, Newark, NJ.
Latha V PasupuletiDepartment of Surgery, Division of Trauma, Rutgers-New Jersey Medical School, Newark, NJ.
Amy V GoreDepartment of Surgery, Division of Trauma, Rutgers-New Jersey Medical School, Newark, NJ.
Ziad C SifriDepartment of Surgery, Division of Trauma, Rutgers-New Jersey Medical School, Newark, NJ.
Kolenkode B KannanDepartment of Surgery, Division of Acute Care Surgery, University of Florida, Gainesville, FL.
Alicia M MohrDepartment of Surgery, Division of Acute Care Surgery, University of Florida, Gainesville, FL. Electronic address: alicia.mohr@surgery.ufl.edu.
Rutgers, The State University of New Jersey · USUniversity of Florida · USRutgers New Jersey Medical School

Funding

Chronic Stress and Anemia Recovery following Major TraumaR01GM105893 · NIGMS · UNIVERSITY OF FLORIDA · PI MOHR, ALICIA M · 2013 to 2021
$3.5M
Training in Trauma and Surgical Critical Care ResearchT32GM069330 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LIVINGSTON, DAVID H · 2004 to 2015
$1.3M
NIGMS NIH HHS R01 GM105893NIGMS NIH HHS R01 GM105893-01A1NIGMS NIH HHS T32 GM069330
6 · The paper itself

Abstract

introductionPropranolol has been shown previously to decrease the mobilization of hematopoietic progenitor cells (HPCs) after acute injury in rodent models; however, this acute injury model does not reflect the prolonged period of critical illness after severe trauma. Using our novel lung contusion/hemorrhagic shock/chronic restraint stress model, we hypothesize that daily administration of propranolol will decrease prolonged mobilization of HPCs without worsening lung healing.

methodsMale Sprague-Dawley rats underwent 6 days of restraint stress after undergoing lung contusion or lung contusion/hemorrhagic shock. Restraint stress consisted of a daily 2-hour period of restraint interrupted every 30 minutes by alarms and repositioning. Each day after the period of restraint stress, the rats received intraperitoneal propranolol (10 mg/kg). On day 7, peripheral blood was analyzed for granulocyte-colony stimulating factor (G-CSF) and stromal cell-derived factor 1 via enzyme-linked immunosorbent assay and for mobilization of HPCs using c-kit and CD71 flow cytometry. The lungs were examined histologically to grade injury.

resultsSeven days after lung contusion and lung contusion/hemorrhagic shock, the addition of chronic restraint stress significantly increased the mobilization of HPC, which was associated with persistently increased levels of G-CSF and increased lung injury scores. The addition of propranolol to lung contusion/chronic restraint stress and lung contusion/hemorrhagic shock/chronic restraint stress models greatly decreased HPC mobilization and restored G-CSF levels to that of naïve animals without worsening lung injury scores.

conclusionThe daily administration of propranolol after both lung contusion and lung contusion/hemorrhagic shock subjected to chronic restraint stress decreased the prolonged mobilization of HPC from the bone marrow and decreased plasma G-CSF levels. Despite the decrease in mobilization of HPC, lung healing did not worsen. Alleviating chronic stress with propranolol may be a future therapeutic target to improve healing after severe injury.

Indexed as

Adrenergic beta-AntagonistsAnimalsBiomarkersChemokine CXCL12ContusionsDrug Administration ScheduleEnzyme-Linked Immunosorbent AssayFlow CytometryGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsInjections, IntraperitonealLung InjuryMalePropranololRandom AllocationRatsAdrenergic beta-AntagonistsBiomarkersChemokine CXCL12CXCL12 protein, ratGranulocyte Colony-Stimulating FactorPropranolol

Identifiers

PMID26209570
PMCPMC4937617
OpenAlexW1935847120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.